Newborn Screening Market Size Worth USD 2.27 Billion By 2027-Emergen Research
The market is being driven by technological advancements, government funding, and an expanding panel of Newborn diseases.
According to a new report by Emergen Research, the Global Newborn Screening Market will be worth USD 2.27 billion by 2027. Infant newborn screening tests look for developmental, metabolic, and genetic abnormalities. More than 30 illnesses and conditions are included in newborn screening. Furthermore, various governmental and non-profit organisations are primarily focused on providing high-quality foetal and maternal care. Furthermore, the industry is expected to see an increase in demand as a result of the involvement of federal bodies in coordinating awareness and quality control programmes to instil confidence and reduce the number of deaths caused by negligence and non-screening. New treatments, such as enzyme replacement therapy, hematopoietic stem cell transplant, gene therapy, and novel therapeutic drugs, have allowed autoimmune disorders to be included as possible diagnoses. candidates enrolled in NBS programmes
Newborn screening includes a variety of tests, such as hearing tests, urine tests, and dry blood tests, that are performed during the first few hours or days of an infant’s life. These tests have the potential to help prevent a variety of health problems and deaths. From a simple blood and urine screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions, newborn screening has evolved.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/4
Some Key Highlights from the Report
Based on the technology, electrophoresis generated a revenue of USD 0.15 billion in 2019 and is predicted to rise with a CAGR of 11.1% in the forecast period owing to the increasing demand and new detection techniques that assist in recognition of amino acids, carnitine conjugates, and other compounds.
The assay kits are expected to grow with a CAGR of 10.4% in the forecasted period, attributable to its wide variety of classes such as enzymatic assay kits, DNA assay kits, immunoassay kits, and others of which immunoassay is a process-oriented used in the screening.
The dry blood spot test application is the major contributor to the Newborn Screening Market. The dry blood spot test application of the North America region is the major shareholder of the market and held around 43.1% of the market in the year 2019.
North America dominated the market with a share of 34.7% in 2019 due to its adoption of cost-effective and innovative procedures.
Emergen Research has segmented the global Newborn Screening Market on the basis of Technology, Product, Application, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
Tandem Mass Spectrometry
Enzyme Based Assay
Product Outlook (Revenue, USD Billion; 2017-2027)
Application Outlook (Revenue, USD Billion; 2017-2027)
Dry Blood Spot Test
Critical Congenital Heart Disease (CCHD)
Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights